Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 344

1.

Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues.

Hui AB, Shi W, Boutros PC, Miller N, Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, Jurisica I, Penn LZ, Liu FF.

Lab Invest. 2009 May;89(5):597-606. doi: 10.1038/labinvest.2009.12. Epub 2009 Mar 16. Erratum in: Lab Invest. 2009 Jun;89(6):726. Waldron, Levi [added].

2.

Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology.

Hasemeier B, Christgen M, Kreipe H, Lehmann U.

BMC Biotechnol. 2008 Nov 27;8:90. doi: 10.1186/1472-6750-8-90.

3.

Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues.

Mullins M, Perreard L, Quackenbush JF, Gauthier N, Bayer S, Ellis M, Parker J, Perou CM, Szabo A, Bernard PS.

Clin Chem. 2007 Jul;53(7):1273-9. Epub 2007 May 24.

4.

Gene expression variation between distinct areas of breast cancer measured from paraffin-embedded tissue cores.

Schobesberger M, Baltzer A, Oberli A, Kappeler A, Gugger M, Burger H, Jaggi R.

BMC Cancer. 2008 Nov 25;8:343. doi: 10.1186/1471-2407-8-343.

5.

Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.

Huang GL, Zhang XH, Guo GL, Huang KT, Yang KY, Shen X, You J, Hu XQ.

Oncol Rep. 2009 Mar;21(3):673-9.

PMID:
19212625
6.

Optimization and analysis of a quantitative real-time PCR-based technique to determine microRNA expression in formalin-fixed paraffin-embedded samples.

Goswami RS, Waldron L, Machado J, Cervigne NK, Xu W, Reis PP, Bailey DJ, Jurisica I, Crump MR, Kamel-Reid S.

BMC Biotechnol. 2010 Jun 23;10:47. doi: 10.1186/1472-6750-10-47.

7.

Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.

Quesne JL, Jones J, Warren J, Dawson SJ, Ali HR, Bardwell H, Blows F, Pharoah P, Caldas C.

J Pathol. 2012 Jul;227(3):306-14. doi: 10.1002/path.3983. Epub 2012 May 8.

PMID:
22294324
8.

Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays.

Ravo M, Mutarelli M, Ferraro L, Grober OM, Paris O, Tarallo R, Vigilante A, Cimino D, De Bortoli M, Nola E, Cicatiello L, Weisz A.

Lab Invest. 2008 Apr;88(4):430-40. doi: 10.1038/labinvest.2008.11. Epub 2008 Feb 25.

9.

Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samples.

Ciotti P, Garuti A, Ballestrero A, Cirmena G, Chiaramondia M, Baccini P, Bellone E, Mandich P.

Diagn Mol Pathol. 2009 Jun;18(2):112-8. doi: 10.1097/PDM.0b013e3181831320.

PMID:
19430292
10.

MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.

Tömböl Z, Eder K, Kovács A, Szabó PM, Kulka J, Likó I, Zalatnai A, Rácz G, Tóth M, Patócs A, Falus A, Rácz K, Igaz P.

Mod Pathol. 2010 Dec;23(12):1583-95. doi: 10.1038/modpathol.2010.164. Epub 2010 Sep 3.

11.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.

12.

Quantitative PCR and HER2 testing in breast cancer: a technical and cost-effectiveness analysis.

Barberis M, Pellegrini C, Cannone M, Arizzi C, Coggi G, Bosari S.

Am J Clin Pathol. 2008 Apr;129(4):563-70. doi: 10.1309/1AKQDQ057PQT9AKX.

13.

Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.

Harbeck N, Nimmrich I, Hartmann A, Ross JS, Cufer T, Grützmann R, Kristiansen G, Paradiso A, Hartmann O, Margossian A, Martens J, Schwope I, Lukas A, Müller V, Milde-Langosch K, Nährig J, Foekens J, Maier S, Schmitt M, Lesche R.

J Clin Oncol. 2008 Nov 1;26(31):5036-42. doi: 10.1200/JCO.2007.14.1697. Epub 2008 Aug 18.

14.

Role of deregulated microRNAs in breast cancer progression using FFPE tissue.

Chen L, Li Y, Fu Y, Peng J, Mo MH, Stamatakos M, Teal CB, Brem RF, Stojadinovic A, Grinkemeyer M, McCaffrey TA, Man YG, Fu SW.

PLoS One. 2013;8(1):e54213. doi: 10.1371/journal.pone.0054213. Epub 2013 Jan 23.

15.

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.

J Clin Oncol. 2009 Apr 20;27(12):2030-7. doi: 10.1200/JCO.2008.19.4134. Epub 2009 Mar 9.

16.

Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.

Sánchez-Navarro I, Gámez-Pozo A, González-Barón M, Pinto-Marín A, Hardisson D, López R, Madero R, Cejas P, Mendiola M, Espinosa E, Vara JA.

Biotechniques. 2010 May;48(5):389-97. doi: 10.2144/000113388.

17.

Real-time quantitative RT-PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues.

Koch I, Slotta-Huspenina J, Hollweck R, Anastasov N, Hofler H, Quintanilla-Martinez L, Fend F.

Diagn Mol Pathol. 2006 Sep;15(3):149-56.

PMID:
16932070
18.

Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.

Sadi AM, Wang DY, Youngson BJ, Miller N, Boerner S, Done SJ, Leong WL.

BMC Cancer. 2011 Jun 16;11:253:1-13. doi: 10.1186/1471-2407-11-25.

19.

Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling.

Szafranska AE, Davison TS, Shingara J, Doleshal M, Riggenbach JA, Morrison CD, Jewell S, Labourier E.

J Mol Diagn. 2008 Sep;10(5):415-23. doi: 10.2353/jmoldx.2008.080018. Epub 2008 Aug 7.

20.

MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.

Yu J, Ohuchida K, Mizumoto K, Fujita H, Nakata K, Tanaka M.

Cancer Biol Ther. 2010 Oct 15;10(8):748-57. doi: 10.4161/cbt.10.8.13083. Epub 2010 Oct 15.

PMID:
20703102
Items per page

Supplemental Content

Write to the Help Desk